Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 551, pseudogene (RN7SL551P)

Target
RN7SL551P
Molecular classification
Other, Pseudogene
01

Overview

RN7SL551P is a pseudogene derived from the 7SL RNA gene family, widely present throughout the human genome as dispersed, noncoding elements[1][5][6][8]. The authentic 7SL RNA gene encodes the RNA core of signal recognition particle (SRP), a ribonucleoprotein essential for the targeting and translocation of newly synthesized proteins to the endoplasmic reticulum[3]. However, RN7SL551P itself is a truncated, non-functional DNA sequence created by the reverse transcription and integration of 7SL RNA-related elements back into the genome[5][6][8]. Pseudogenes like RN7SL551P do not produce functional RNA or protein products, are not actively transcribed, and are not considered molecular targets for drug development[1][5][6][8]. In certain research contexts, patterns of pseudogene expression and formation may have biomarker or prognostic value, especially in cancer profiling, though specific roles for RN7SL551P remain unconfirmed and it does not act as a molecular target[4]. Key points: - RN7SL551P is not a receptor, enzyme, transporter, or any other classical drug target. - It is non-functional and best classified as a pseudogene. - Clinical and biological relevance is limited to potential research applications in genomics/bioinformatics, not as a therapeutic target. - There may be confusion in target databases because 7SL RNA itself is a functional molecule, but RN7SL551P is not[1][5][6][8].

Other names
RN7SL551PRNA, 7SL, cytoplasmic 551, pseudogene
02

Biological functions

None
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 551, pseudogene (RN7SL551P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 551, pseudogene (RN7SL551P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call